Leqembi 100 mg/mL concentrate for solution for infusion
*Company:
Eisai LtdStatus:
NewLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 08 September 2025
File name
ROI Leqembi SmPC June 2025.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 08 September 2025
File name
ROI Leqembi PIL April 2025.pdf
Reasons for updating
- New PIL for new product
Eisai Ltd
Address:
EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN, UKMedical Information E-mail:
EUMedInfo@eisai.netTelephone:
+44 (0)208 600 1400Website:
https://www.eisai.eu